Name: BMS-986020 sodium
SKU: A21842
Price: 54 USD
Rating: 5 (288 reviews)

Catalog No.

Product Name

Application

Product Information

Product Citation

A10501

Ki16425

LPA Receptor Antagonist

Ki16425 is a LPA receptor antagonist with selectivity for LPA1 and LPA3 and exhibits Ki values of 0.34, 6.5, and 0.93 μM for the human LPA1, LPA2, and LPA3 receptors, respectively.

Quick View
- Maria F Fernandes, .et al. , Int J Mol Sci, 2022, Apr 9;23(8):4163 PMID: 35456981
- Rieko Suenaga, .et al. , PLoS One, 2022, Feb 3;17(2):e0263296 PMID: 35113924
- Inoue A, .et al. , Cell, 2019, Jun 13;177(7):1933-1947 PMID: 31160049
- Taniguchi R, .et al. , Nature, 2017, Aug 17;548(7667):356-360 PMID: 28792932
- T. HASHIMOTO, .et al. , Br J Dermatol., 2015, Nov;173(5):1334-6 PMID: 26122943
A11966

Ki16198

LPA Receptor antagonist

Ki16198 is a potent LPA receptor antagonist and inhibits LPA1- and LPA3-induced inositol phosphate production with Ki of 0.34 μM and 0.93 μM, respectively.

Quick View
A12156

SAR-100842

lysophaphatidic acid 1 (LPA1/Edg-2) receptor inhibitor

SAR-100842 is a lysophaphatidic acid 1 (LPA1/Edg-2) receptor inhibitor.

Quick View
A13981

AM095

LPA1 receptor antagonist

AM095 is a potent LPA1 receptor antagonist because it inhibited GTP??S binding to Chinese hamster ovary (CHO) cell membranes overexpressing recombinant human or mouse LPA1 with IC50 values of 0.98 and 0.73 μM, respectively, and exhibited no LPA1 agonism.

Quick View
A14180

AM095 free base

LPA1 Receptor antagonist

AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 μM for mouse or recombinant human LPA1, respectively

Quick View
A20393

BMS-986020

LPA1 antagonist

BMS-986020 is a high-affinity lysophosphatidic acid receptor 1 (LPA1) antagonist.

Quick View
A21842

BMS-986020 sodium

LPA1 antagonist

BMS-986020 sodium is a high-affinity lysophosphatidic acid receptor 1 (LPA1) antagonist.

Quick View

LPA Receptor